Ectoparasite control agent

US9474740B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9474740-B2
Application numberUS-201414771866-A
CountryUS
Kind codeB2
Filing dateFeb 28, 2014
Priority dateMar 8, 2013
Publication dateOct 25, 2016
Grant dateOct 25, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

wherein, in formula (III), X 1 represents a C1-6 alkyl group which is unsubstituted or has a substituent, or other groups; m1 represents any integer of 0 to 5; A represents an oxygen atom or a sulfur atom; each of R 1 and R 2 independently represents a hydrogen atom, a C1-6 alkyl group which is unsubstituted or has a substituent, or other groups; R 5 represents a hydrogen atom or a C1-6 alkyl group which is unsubstituted or has a substituent; B represents an oxygen atom or a sulfur atom; Q 2 represents a C7-11 aralkyl group which is unsubstituted or has a substituent X 2 , or other groups; and each of R 3a , R 3b , R 4a , and R 4b independently represents a hydrogen atom, a C1-6 alkyl group which is unsubstituted or has a substituent, or other groups.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for suppressing parasites in the body or on the body surface of an animal requiring suppression of parasite by parasitic organisms, wherein an effective amount of at least one compound selected from the 1-heterodiene compounds of Formula (I) and salts thereof is administered to the animal, wherein Formula (I) is: wherein, in Formula (I), Q 1 represents a C6-10 aryl group which is unsubstituted or has a substituent X 1 , or a 5- or 6-membered heteroaryl group which is unsubstituted or has a substituent X 1 ; X 1 represents a C1-6 alkyl group which is unsubstituted or has a substituent, a C2-6 alkenyl group which is unsubstituted or has a substituent, a C2-6 alkenyl group which is unsubstituted or has a substituent, a C3-8 cycloalkyl group which is unsubstituted or has a substituent, a hydroxyl group, a C1-6 alkoxy group which is unsubstituted or has a substituent, a C1-7 acyl group which is unsubstituted or has a substituent, a C1-6 alkoxycarbonyl group which is unsubstituted or has a substituent, an amino group which is unsubstituted or has a substituent, a C1-6 alkylthio group which is unsubstituted or has a substituent, a C1-6 alkylsulfonyl group which is unsubstituted or has a substituent, a C6-10 aryl group which is unsubstituted or has a substituent, a 3- to 6-membered heterocyclic group which is unsubstituted or has a substituent, a halogeno group, a cyano group, or a nitro group; the number of the substituent X 1 on Q l is any integer of 1 to 5; and when the number of the substituent X 1 is 2 or greater, X 1 s may be the same as or different from each other; A represents an oxygen atom or a sulfur atom; each of R 1 and R 2 independently represents a hydrogen atom, a C1-6 alkyl group which is unsubstituted or has a substituent, a C2-6 alkenyl group which is unsubstituted or has a substituent, a C2-6 alkynyl group which is unsubstituted or has a substituent, a C3-8 cycloalkyl group which is unsubstituted or has a substituent, a C6-10 aryl group which is unsubstituted or has a substituent, a 3- to 6-membered heterocyclic group which is unsubstituted or has a substituent, or a cyano group; an exomethylene group which is unsubstituted or has a substituent maybe formed by R 1 and R 2 being taken together; each of R 3 and R 4 independently represents a hydrogen atom, a C1-6 alkyl group which is unsubstituted or has a substituent, a C2-6 alkenyl group which is unsubstituted or has a substituent, a C2-6 alkynyl group which is unsubstituted or has a substituent, a C3-8 cycloalkyl group which is unsubstituted or has a substituent, a C6-10 aryl group which is unsubstituted or has a substituent, a 3- to 6-membered heterocyclic group which is unsubstituted or has a substituent, a halogeno group, or a cyano group; n represents the number of methylene substituted with R 3 and R 4 , and is any integer of 1 to 4; and when n is 2 or greater. R 3 and R 4 may be the same as or different from each other; R 3 and R 4 may be connected to each other and form a ring together with the carbon atom to which R 3 and R 4 are bonded; R 5 represents a hydrogen atom or a C1-6 alkyl group which is unsubstituted or has a substituent; B represents an oxygen atom or a sulfur atom; Q 2 represents a C7-11 aralkyl group which is unsubstituted or has a substituent X 2 , a C6-10 aryl group which is unsubstituted or has a substituent X 2 , or a 5- or 6-membered heteroaryl group which is unsubstituted or has a substituent X 2 ; X 2 represents a C1-6 alkyl group which is unsubstituted or has a substituent, a C2-6 alkenyl group which is unsubstituted or has a substituent, a C2-6 alkynyl group which is unsubstituted or has a substituent, a C3-8 cycloalkyl group which is unsubstituted or has a substituent, a hydroxyl group, a C1-6 alkoxy group which is unsubstituted or has a substituent, a C1-7 acyl group which is unsubstituted or has a substituent, a C1-6 alkoxycarbonyl group which is unsubstituted or has a substituent, an amino group which is unsubstituted or has a substituent, a C1-6 alkylthio group which is unsubstituted or has a substituent, a C1-6 alkylsulfonyl group which is unsubstituted or has a substituent, a C6-10 aryl group which is unsubstituted or has a substituent, a 3- to 6-membered heterocyclic group which is unsubstituted or has a substituent, a halogeno group, a cyano group, or a nitro group; the number of the substituent X 2 on Q 2 is any integer of 1-5; and when the number of the substituent X 2 is 2 or greater, X 2 s may be the same as or different from each other; and according to the stereoisomerism of the double bond to which R 5 and B arc bonded in Formula (I) the compound shows (E), (Z), or (E/Z). 2. The method according to claim 1 , wherein at least one other effective component is administered to the animal. 3. The method according to claim 1 , wherein the animal is a human. 4. The method according to claim 1 , wherein the animal is a pet. 5. The method according to claim 4 , wherein the pet is a dog or a cat. 6. The method according to claim 1 , wherein the animal is livestock. 7. The method according to claim 1 , wherein the parasite is a tick. 8. A method for suppressing insects and mites which are parasitic on or infect animals, wherein at least one compound selected from the 1-heterodiene compounds and salts thereof according to Formula (I) acts on the insects and mites which are parasitic on or infect animals and/or the habitat thereof, wherein Formula (I) is: wherein, in Formula (I), Q 1 represents a C6-10 aryl group which is unsubstituted or has a substituent X 1 , or a 5- or 6-membered heteroaryl group which is unsubstituted or has a substituent X 1 ; X 1 represents a C1-6 alkyl group which is unsubstituted or has a substituent, a C2-6 alkenyl group which is unsubstituted or has a substituent, a C2-6 alkynyl group which is unsubstituted or has a substituent, a C3-8 cvcloalkyl group which is unsubstituted or has a substituent, a hydroxyl group, a C1-6 alkoxv group which is unsubstituted or has a substituent a C1-7 acyl group which is unsubstituted or has a substituent, a C1-6 alkoxycarbonyl group which is unsubstituted or has a substituent, an amino group which is unsubstituted or has a substituent, a C1-6 alkylthio group which is unsubstituted or has a substituent, a C1-6 alkylsulfonyl group which is unsubstituted or has a substituent, a C6-10 aryl group which is unsubstituted or has a substituent, a 3- to 6-membered heterocyclic group which is unsubstituted or has a substituent, a halogeno group, a cyano group, or a nitro group; the number of the substituent X 1 on Q 1 is any integer of 1 to 5; and when the number of the substituent X 1 is 2 or greater, X 1 s may be the same as or different from each other; A represents an oxygen atom or a sulfur atom: each of R 1 and R 2 independently represents a hydrogen atom, a C1-6 alkyl group which is unsubstituted or has a substituent, a C2-6 alkenyl group which is unsubstituted or has a substituent, a C2-6 alkynyl group which is unsubstituted or has a substituent, a C3-8 cycloalkyl group which is unsubstituted or has a substituent a C6-10 aryl group which is unsubstituted or has a substituent, a 3- to 6-membered heterocyclic group which is unsubstituted or has a substituent, or a cyano group; an exomethylene group which is unsubstituted or has a substituent may be formed by R 1 and R 2 being taken together; each of R 3 and R 4 independently represents a hydrogen atom, a C1-6 alkyl group which is unsubstituted or

Assignees

Inventors

Classifications

  • not condensed with other rings · CPC title

  • with sulfur as the ring hetero atom · CPC title

  • A61K31/382Primary

    having six-membered rings, e.g. thioxanthenes (thiothixene A61K31/496) · CPC title

  • with sulfur as the ring hetero atom · CPC title

  • with oxygen as the ring hetero atom · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9474740B2 cover?
wherein, in formula (III), X 1 represents a C1-6 alkyl group which is unsubstituted or has a substituent, or other groups; m1 represents any integer of 0 to 5; A represents an oxygen atom or a sulfur atom; each of R 1 and R 2 independently represents a hydrogen atom, a C1-6 alkyl group which is unsubstituted or has a substituent, or other groups; R 5 represents a hydrogen atom or a C1-6 alk…
Who is the assignee on this patent?
Nippon Soda Co
What technology area does this patent fall under?
Primary CPC classification A61K31/382. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).